Market Tracker

08/21 7:37am ET

Hemispherx Biopharma Inc (NYSE American:HEB)

0.40
Delayed Data
As of Aug 18
 +0.016 / +4.17%
Today’s Change
0.30
Today|||52-Week Range
2.64
-42.01%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.38
Today’s open0.38
Day’s range0.36 - 0.41
Volume87,847
Average volume (3 months)311,178
Market cap$11.7M
Dividend yield--
Data as of 08/18/2017

Growth & Valuation

Earnings growth (last year)+52.78%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)-30.83%
P/E ratioNM
Price/Sales163.59
Price/Book0.62

Competitors

 Today’s
change
Today’s
% change
SBOTStellar Biotechnolog...+0.01+0.88%
RPRXRepros Therapeutics ...-0.00-0.66%
ARGSArgos Therapeutics I...-0.01-5.30%
EVARLombard Medical Inc+0.04+8.04%
Data as of 3:59pm ET, 08/18/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$92.0K
Annual profit (last year)-$7.5M
Net profit margin-8,154.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Vice Chairman, President &
CEO
Thomas Kenwood Equels
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts